BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 24412262)

  • 1. Dominance of the strongest: inflammatory cytokines versus glucocorticoids.
    Dejager L; Vandevyver S; Petta I; Libert C
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):21-33. PubMed ID: 24412262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance.
    Ingawale DK; Mandlik SK; Patel SS
    J Complement Integr Med; 2015 Mar; 12(1):1-13. PubMed ID: 25503867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Mechanisms of Glucocorticoids.
    Vandewalle J; Luypaert A; De Bosscher K; Libert C
    Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma.
    Umland SP; Schleimer RP; Johnston SL
    Pulm Pharmacol Ther; 2002; 15(1):35-50. PubMed ID: 11969362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory actions of glucocorticoids: molecular mechanisms.
    Barnes PJ
    Clin Sci (Lond); 1998 Jun; 94(6):557-72. PubMed ID: 9854452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The mechanism of glucocorticoid resistance in multiple sclerosis].
    Rzazewska-Makosa B
    Postepy Hig Med Dosw (Online); 2005 Sep; 59():457-63. PubMed ID: 16177666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.
    De Iudicibus S; Franca R; Martelossi S; Ventura A; Decorti G
    World J Gastroenterol; 2011 Mar; 17(9):1095-108. PubMed ID: 21448414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
    Vandevyver S; Dejager L; Tuckermann J; Libert C
    Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts in glucocorticoid resistance.
    Yang N; Ray DW; Matthews LC
    Steroids; 2012 Sep; 77(11):1041-9. PubMed ID: 22728894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous glucocorticoids inhibit myocardial inflammation induced by lipopolysaccharide: involvement of regulation of histone deacetylation.
    Zhang HN; He YH; Zhang GS; Luo MS; Huang Y; Wu XQ; Liu SM; Luo JD; Chen MS
    J Cardiovasc Pharmacol; 2012 Jul; 60(1):33-41. PubMed ID: 22472906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular interaction between the glucocorticoid receptor and MAPK signaling pathway: a novel link in modulating the anti-inflammatory role of glucocorticoids.
    Kharwanlang B; Sharma R
    Indian J Biochem Biophys; 2011 Aug; 48(4):236-42. PubMed ID: 22053692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear translocation of the glucocorticoid receptor in fibroblasts of asthmatic patients with nasal polyposis insensitive to glucocorticoid treatment.
    Embid C; Fernández-Bertolín L; Pujols L; Alobid I; Mullol J; Picado C
    Arch Bronconeumol; 2011 Mar; 47(3):115-21. PubMed ID: 21288619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
    Löwenberg M; Stahn C; Hommes DW; Buttgereit F
    Steroids; 2008 Oct; 73(9-10):1025-9. PubMed ID: 18221974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between TNF and glucocorticoid receptor signaling pathways.
    Van Bogaert T; De Bosscher K; Libert C
    Cytokine Growth Factor Rev; 2010 Aug; 21(4):275-86. PubMed ID: 20456998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid receptor beta in acute and chronic inflammatory conditions: clinical implications.
    Goecke A; Guerrero J
    Immunobiology; 2006; 211(1-2):85-96. PubMed ID: 16446173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5α-Reduced glucocorticoids: a story of natural selection.
    Nixon M; Upreti R; Andrew R
    J Endocrinol; 2012 Feb; 212(2):111-27. PubMed ID: 21903862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized glucocorticoid therapy: teaching old drugs new tricks.
    Strehl C; Buttgereit F
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid resistance as a major drive in sepsis pathology.
    Dendoncker K; Libert C
    Cytokine Growth Factor Rev; 2017 Jun; 35():85-96. PubMed ID: 28479044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis.
    Koenen M; Culemann S; Vettorazzi S; Caratti G; Frappart L; Baum W; Krönke G; Baschant U; Tuckermann JP
    Ann Rheum Dis; 2018 Nov; 77(11):1610-1618. PubMed ID: 29997111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.
    Hapgood JP; Avenant C; Moliki JM
    Pharmacol Ther; 2016 Sep; 165():93-113. PubMed ID: 27288728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.